Published: Nov 03, 2021
SHENZHEN, China, Nov. 3, 2021 /PRNewswire/ -- As
reported by Indonesian National Agency of Drug and Food Control (BPOM), BPOM
grants the Emergency Use Authorization (EUA) for COVID-19 Vaccine
(ChAdOx1-S[recombinant])/KconecaVac manufactured by Shenzhen Kangtai Biological
Products Co., Ltd.. It is understood that this is China's second
adenovirus vector COVID-19 vaccine approved for emergency use overseas.
SOURCE Shenzhen Kangtai Biological Products Co., Ltd.
Company Codes: Shenzhen: 300601
China, Malaysia companies inks deal on clinical trial, commercialization of COVID-19 vaccines
COVID-19: A Basic Guide to Different Vaccine Types and How They Work
With global push for COVID-19 vaccines, China aims to win friends and cut deals